Mauro Loi

9PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Tumour immunologyPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2024
From twilight to starlight? Debating the role of chemoradiotherapy in gastric cancer in the D2 dissection era.

Mauro Loi, Marcel Verheij, Joost Nuyttens

|Feb 25, 2022
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer.

M Loi, G Salvatore, M Sottili

|Sep 18, 2020
Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.

Mauro Loi, Tiziana Comito, Ciro Franzese

|Sep 25, 2018
Pain flare, complexity and analgesia in bone oligometastases treated with stereotactic body radiation therapy.

Mauro Loi, Natalie D Klass, Kim C De Vries

|Aug 02, 2018
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.

Mauro Loi, Isacco Desideri, Emanuela Olmetto

Pageof 2